Published in New Horiz on May 01, 1998
Laparoscopic colorectal surgery: learning curve and training implications. Postgrad Med J (2005) 1.03
Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99
Fast track colorectal surgery. Clin Colon Rectal Surg (2009) 0.83
Gut oxygenation and oxidative damage during and after laparoscopic and open left-sided colon resection: a prospective, randomized, controlled clinical trial. Surg Endosc (2010) 0.79
Fast-track surgery: Toward comprehensive peri-operative care. Anesth Essays Res (2015) 0.78
Preoperative assessment of the older surgical patient: honing in on geriatric syndromes. Clin Interv Aging (2014) 0.75
Assessing the effects of modality of surgery on postoperative weight loss in patients undergoing partial nephrectomy. World J Urol (2016) 0.75
Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth (1997) 3.97
Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg (1997) 3.10
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst (1999) 1.64
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians (1999) 1.62
Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61
Serum YKL-40 and colorectal cancer. Br J Cancer (1999) 1.57
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Eur J Surg Oncol (2000) 1.48
Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg (2000) 1.47
Surgical stress: the role of pain and analgesia. Br J Anaesth (1989) 1.47
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer (2002) 1.47
Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res (2000) 1.31
Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ (1999) 1.29
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res (2000) 1.27
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem (1997) 1.26
Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum (2001) 1.24
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer (1999) 1.24
Postoperative opioid analgesia: time for a reconsideration? J Clin Anesth (1996) 1.15
Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat (1997) 1.09
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest (2002) 1.07
Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99
Balanced analgesia: what is it and what are its advantages in postoperative pain? Drugs (1999) 0.99
Effect of prednisolone on the systemic response and wound healing after colonic surgery. Arch Surg (1997) 0.98
Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol (2012) 0.97
Postoperative morbidity among symptom-free alcohol misusers. Lancet (1992) 0.96
Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am J Hematol (2001) 0.95
[Side effects of perioperative blood transfusion--still a challenge]. Ugeskr Laeger (1993) 0.95
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res (1998) 0.94
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol (2004) 0.94
The surgical stress response: should it be prevented? Can J Surg (1991) 0.93
The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl (1989) 0.91
Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J Immunol Methods (1994) 0.90
Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Scand J Immunol (2011) 0.90
Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem (2001) 0.90
The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol (2000) 0.89
Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions. Br J Haematol (1998) 0.89
Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand J Clin Lab Invest (2007) 0.89
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol (2007) 0.89
Quality of reinfused drainage blood after total knee arthroplasty. J Arthroplasty (1999) 0.88
Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptors. APMIS (1991) 0.88
The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. Int J Obes (Lond) (2011) 0.88
The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. Eur J Surg (2001) 0.87
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1. Int J Biol Markers (2008) 0.87
Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients. Scand J Immunol (2005) 0.87
Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scand J Rheumatol (2007) 0.87
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study. Eur J Cancer (2004) 0.87
Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer. Br J Cancer (2009) 0.86
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1). Inflamm Res (2005) 0.84
Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay. Int J Biol Markers (2003) 0.83
Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Biol Markers (2007) 0.83
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. Gynecol Oncol (2001) 0.83
Are perioperative nonsteroidal anti-inflammatory drugs ulcerogenic in the short term? Drugs (1992) 0.83
A randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery. Tech Coloproctol (2014) 0.83
DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry (1999) 0.82
Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests. Eur Surg Res (1992) 0.82
Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components. Scand J Clin Lab Invest (2002) 0.82
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. Ann Oncol (2010) 0.82
Blood loss and transfusion after total mesorectal excision and conventional rectal cancer surgery. Colorectal Dis (2004) 0.81
The modifying effect of anesthetic technique on the metabolic and endocrine responses to anesthesia and surgery. Acta Anaesthesiol Belg (1988) 0.81
Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia (1995) 0.81
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. APMIS (1999) 0.81
Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol (1998) 0.81
Cardiovascular and respiratory changes and convalescence in laparoscopic colonic surgery: comparison between carbon dioxide pneumoperitoneum and gasless laparoscopy. Arch Surg (1999) 0.81
Postoperative pain. World J Surg (1993) 0.81
A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1996) 0.80
A consistent shift in VEGF determinations between two different ELISA batch numbers. Br J Cancer (2003) 0.80
Immunomodulating effect of blood transfusion: is storage time important? Vox Sang (1998) 0.80
Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer. Scand J Clin Lab Invest (2007) 0.79
1993 John J. Bonica Lecture. Postoperative pain relief. A look from the other side. Reg Anesth (1995) 0.79
Soluble urokinase plasminogen activator receptor in blood transfusion components. Transfus Med (2004) 0.79
Balanced analgesia: a prerequisite for optimal recovery. Br J Surg (1998) 0.79
The role of tissue factor in colorectal cancer. Eur J Surg Oncol (2003) 0.79
The effect of ranitidine on postoperative infectious complications following emergency colorectal surgery: a randomized, placebo-controlled, double-blind trial. Inflamm Res (1998) 0.78
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. Anticancer Res (2009) 0.78
Accumulation of the neutrophil-derived protein YKL-40 during storage of various blood components. Inflamm Res (2001) 0.78
Ranitidine reduces postoperative interleukin-6 induced C-reactive protein synthesis. J Am Coll Surg (1995) 0.78
Bacterial antigen induced release of soluble vascular endothelial growth factor (VEGF) and VEGFR1 before and after surgery. Scand J Clin Lab Invest (2005) 0.77
Identifying sources and estimating glandular output of salivary TIMP-1. Scand J Clin Lab Invest (2008) 0.77
Loss of ELISA specificity due to biotinylation of monoclonal antibodies. J Immunol Methods (2000) 0.77
[Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors]. Ugeskr Laeger (2000) 0.77
Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. Int J Biol Markers (2005) 0.77
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration. Int J Biol Markers (2005) 0.77
Cytokeratin-positive cells in preoperative peripheral blood and bone marrow aspirates of patients with colorectal cancer. Scand J Clin Lab Invest (2002) 0.76
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer. Int J Biol Markers (2006) 0.76
Late post-operative hypoxaemia and organ dysfunction. Eur J Anaesthesiol Suppl (1995) 0.76
Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy (1995) 0.75
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue. Mol Oncol (2007) 0.75
Decreased tetranectin in multiple myeloma. Am J Hematol (1990) 0.75
Effect of heating on extracellular bioactive substances in stored human blood: in vitro study. J Trauma (1997) 0.75
[Immunologic consequences of surgery, anesthesia and blood transfusion. Surgical immunosuppression]. Ugeskr Laeger (1989) 0.75
[Aortofemoral bypass and extensive profunda-plasty in combined arterial occlusive disease of the pelvic-femoral type--a stage oriented analysis]. Vasa (1993) 0.75
[The effect of prednisolone on the systemic response and wound healing after colonic surgery]. Ugeskr Laeger (1998) 0.75
[Postoperative morbidity among alcohol abusers]. Ugeskr Laeger (1994) 0.75
[Leukocyte filtration in elective colorectal surgery. Reduced transfusion associated immunosuppression after bedside procedures]. Ugeskr Laeger (1997) 0.75
[Histamine-2 blockade in psoriasis]. Ugeskr Laeger (1991) 0.75
Ranitidine for improvement of treatment-resistant psoriasis. Arch Dermatol (1991) 0.75
Possible effect of histamine-2 receptor blockade on the antitumour response to interleukin-2. Eur J Cancer (1995) 0.75
Systemic high-dose ranitidine in the treatment of psoriasis: an open prospective clinical trial. Br J Dermatol (1995) 0.75
The endocrine responses to regional anesthesia. Int Anesthesiol Clin (1988) 0.75
Various functions of PBMC from colon cancer patients are not decreased compared to healthy blood donors. Cancer Biother Radiopharm (1997) 0.75
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration. Int J Biol Markers (2017) 0.75